Following the launch of HERA earlier this month, work is now beginning in earnest on some of its key activities such as mapping, manufacturing, stockpiling and bringing medical countermeasures to market. Three calls for tender focusing on COVID-19 therapeutics and antimicrobial resistance have just been published:

• Study on bringing AMR medical countermeasures to market
• Feasibility study on stockpiling of medical countermeasures in the area of AMR
• Feasibility study, design and prototype development for an EU mapping platform for COVID-19 therapeutics

The European Commission is allocating €7 million from the EU4Health programme to these activities.
The calls for tenders will be open until 29 October 2021.

An online info day on these open calls for tender will take place in early October 2021.